Browse all articles in News & Views

The European Medicines Agency (EMA) has announced that they are beginning a review of domperidone, an antiemetic, because of concerns about adverse cardiac events.¹

Increased potassium intake reduces blood pressure in people with hypertension and has no adverse effect on blood lipid concentrations, catecholamine concentrations, or renal function in adults, according to a study¹ published recently in the British Medical Journal.

Histamine H2-receptor antagonist famotidine does not affect the pharmacokinetics of apixaban in healthy subjects, suggesting that apixaban can be administered without regard to coadministration of gastric acid modifiers, according to a study¹ published recently in Clinical Pharmacology: Advances and Applications.

People deemed to be “mentally vulnerable” are at a significantly increased risk of both fatal and non-fatal cardiovascular disease (CVD), independently of classical risk factors, according to results of a large population study¹ from Denmark, presented recently at the EuroPRevent 2013 congress in Rome.

Despite their greater life expectancy, the adults of today are less “metabolically” healthy than their counterparts of previous generations, according to a large cohort study¹ from the Netherlands comparing generational shifts in well-established metabolic risk factors for cardiovascular disease, published recently in the European Journal of Preventive Cardiology.

Novel oral anticoagulants (NOACs) reduced stroke risk in the elderly population with atrial fibrillation (AF), and overcome many of the disadvantages of warfarin, according to a study¹ published recently in the International Journal of General Medicine.

Green tea and coffee may help lower your risk of having a stroke, especially when both are a regular part of your diet, according to research¹ published recently in Stroke.

A portfolio of quadripolar leads (Attain Performa®, Medtronic, Inc.) has received CE Mark and is to begin its European launch. The left-heart leads feature four electrodes with 16 pacing configurations. The leads are not approved for sale in the USA.

In conjunction with International Women’s Day (8 March 2013), the European Society of Cardiology (ESC) has released a statement reminding women that they may be at a greater risk for cardiovascular disease (CVD) than they think.

Stroke rates are higher on oral anticoagulants (OACs) with some patient clinical characteristics, which could potentially be used to consider a risk assessment tool to flag up high-risk patients while on an OAC, according to a study¹ published recently in Stroke.